SmarterDividends

ACA vs CTATF: Which Is the Better Dividend Stock?

As of Oct 8, 2026, CTATF (Contemporary Amperex Technology Co., Limited) screens as the stronger dividend stock, winning 4 of 4 head-to-head metrics. CTATF offers the higher yield at 0.34%, ACA has the higher dividend-safety score, and CTATF looks like the better value (its fair-value estimate is 32% below its share price).

Key facts: ACA vs CTATF

Data as of · Source: SmarterDividends data

  • As of Oct 8, 2026, Contemporary Amperex Technology Co., Limited (CTATF) has the higher forward dividend yield at 0.34%, versus 0.14% for Arcosa, Inc. (ACA).
  • As of Oct 8, 2026, ACA's fair-value estimate is 68% below its share price and CTATF's fair-value estimate is 32% below its share price, so CTATF looks like the better value of the two on SmarterDividends' blended model.
Cite this page

SmarterDividends, "ACA vs CTATF: Dividend Yield, Safety & Value Compared," updated Oct 8, 2026, https://smarterdividends.com/compare/aca-vs-ctatf

MetricACACTATF
Forward yield0.14%0.34%
Annual dividend$0.20$0.40
Payout ratio5%0%
Years of growth0 yr0 yr
5-yr dividend growth0.0%—
5-yr total return183%—
Dividend safety score84 (A)—
Fair value estimate$47.57$42.20
Upside to fair value-68%-32%
Frequencyquarterlyannual
Market cap$7.2B$285.1B
P/E ratio36.123.0

Higher yield

CTATF

0.34%

Safer dividend

ACA

Grade A

Faster growth

ACA

0.0%

Better value

CTATF

-32% upside

ACA vs CTATF — FAQ

Is ACA or CTATF a better dividend stock?

On the data, CTATF wins more head-to-head categories (4 vs 0). CTATF offers the higher yield (0.34%), while ACA has the stronger dividend-safety score. The right pick depends on whether you prioritise income, safety or value.

Which has a higher dividend yield, ACA or CTATF?

CTATF has the higher forward dividend yield at 0.34%, versus 0.14% for ACA.

Is ACA or CTATF safer?

Compare each stock's payout ratio, growth streak and cut history on its detail page to judge safety.

Is ACA or CTATF better value right now?

As of Oct 8, 2026, CTATF looks like the better value: its fair-value estimate is 32% below its share price (overvalued). For ACA, its fair-value estimate is 68% below its share price.

See more dividend stock comparisons · data refreshes daily · for informational purposes only, not investment advice.